Showing results (31-40 of 103) with videos related to
Sort By:
Pageof 11
Leukemia|October 1, 1991
The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cellsH J Bühring, A Ullrich, K Schaudt, et al.Blood|February 3, 1998
Analysis of c-kit receptor dimerization by fluorescence resonance energy transferV C Broudy, N L Lin, H J Bühring, et al.Hybridoma|February 1, 1991
The monoclonal antibody 11G7 recognizes a novel differentiation antigen expressed on hemopoietic precursor cellsH J Bühring, A Saalmüller, C Müller, et al.The Journal of Experimental Medicine|May 1, 1988
Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised hostW Mutter, M J Reddehase, F W Busch, et al.Journal of Cellular Physiology|March 1, 1994
Epitope mapping and functional studies with three monoclonal antibodies to the c-kit receptor tyrosine kinase, YB5.B8, 17F11, and SR-1L K Ashman, H J Bühring, G W Aylett, et al.Annals of Hematology|November 1, 1991
In vivo induction of HLA molecules in patients with myeloproliferative syndrome during IFN alpha treatmentC A Müller, J Walz, R Zinser, et al.International Archives of Allergy and Immunology|January 30, 2002
Hymenoptera-venom-induced upregulation of the basophil activation marker ecto-nucleotide pyrophosphatase/phosphodiesterase 3 in sensitized individualsI J Platz, M Binder, A Marxer, et al.International Journal of Cancer|May 20, 1998
Endoglin, a component of the TGF-beta receptor system, is a differentiation marker of human choriocarcinoma cellsA Letamendía, P Lastres, N Almendro, et al.Annals of the New York Academy of Sciences|June 18, 1999
Characterization of purified and ex vivo manipulated human hematopoietic progenitor and stem cells in xenograft recipientsT A Bock, B L Ziegler, H J Bühring, et al.Annals of Hematology|February 1, 1992
Phenotypic and clinical heterogeneity of CD56-positive acute nonlymphoblastic leukemiaM A Reuss-Borst, B Steinke, H D Waller, et al.Pageof 11